Carlos Arturo Camargo Jr., Dr.P.H., M.D.
This page shows the publications co-authored by Carlos Camargo and Timothy Lax.
Extended carboplatin infusion does not reduce frequency of hypersensitivity reaction at initiation of retreatment in patients with recurrent platinum-sensitive ovarian cancer. J Allergy Clin Immunol Pract. 2017 Jan - Feb; 5(1):177-178.
Utility of Risk Stratification for Paclitaxel Hypersensitivity Reactions. J Allergy Clin Immunol Pract. 2018 Jul - Aug; 6(4):1266-1273.e2.
Management of hypersensitivity reactions to Carboplatin and Paclitaxel in an outpatient oncology infusion center: a 5-year review. J Allergy Clin Immunol Pract. 2014 Jul-Aug; 2(4):428-33.
The connection strength for co-authors is the sum of the scores for each of their shared publications.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.